http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007121505-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 |
| filingDate | 2005-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007121505-A |
| titleOfInvention | COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS |
| abstract | 1. The compound of formula I: in which U, V and W are independently selected from the group consisting of CR and N; where R is selected from the group consisting of hydrogen and C-C1-6alkyl; Q is selected from the group consisting of NR, NNR, NO, and CR; where R is selected from the group consisting of hydrogen and C-C1-6alkyl; L is selected from the group consisting of -NRC (O) -, -NRC (O) NR-, -C (O) NR-, -NR-, and C-heteroaryl; where R is selected from the group consisting of hydrogen and C-C1-6alkyl; L is selected from the group comprising a bond, -O-, -NRC (O) -, -NRC (O) NR-, -C (O) NR- and -NR-; where R is selected from the group consisting of hydrogen and C-C1-6alkyl; n is 0 or 1; m is 0, 1, 2, 3 or 4; R is selected from the group consisting of C-Saryl, C-heteroaryl, C-cycloalkyl and C-heterocycloalkyl ; where any aryl, heteroaryl, cycloalkyl or heterocycloalkyl contained in R is optionally substituted with 1-3 radicals independently selected from the group consisting of halogen, amino group, nitro group, cyano group, C-C1-6 alkyl, C-alkoxy group, halogen-substituted C-C1-6 alkyl, halogen-substituted -Salkoxy, C-Saryl-C-C1-6alkyl, C-heteroaryl-C-C1-6alkyl, C-Cycloalkyl-C-C1-6alkyl and C-heterocycloalkyl-C-C1-6alkyl; where the methylene fragment of any alkyl group may optionally be replaced by oxygen; where any aryl, heteroaryl, cycloalkyl or heterocycloalkyl substituent contained in R may optionally be substituted with 1 to 3 radicals independently selected from the group consisting of C-C1-6alkyl, C-alkoxy, halogen-substituted C-C1-6alkyl; halogen-substituted C-alkoxy; and hydroxy-substituted C-C1-6alkyl; R is selected from the group consisting of halogen, amino group, nitro group, cyano group, C-C1-6alkyl, C-Salkoxy, halogen-substituted C-C1-6alkyl, halogen-substituted C-Salkoxy-group, C-Saryl-C-C1-6alkyl, C-Cheteroaryl-C-C1-6alkyl -C-C1-6alkyl and C-heterocycloalk |
| priorityDate | 2004-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 278.